Share Name Share Symbol Market Type Share ISIN Share Description
Medicx Fund LSE:MXF London Ordinary Share GG00B1DVQL92 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 90.25p 89.50p 90.25p 90.50p 89.50p 89.75p 178,283.00 12:11:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Real Estate Investment & Services 32.8 39.1 9.9 9.1 357.22

Medicx Fund Share Discussion Threads

Showing 176 to 198 of 200 messages
Chat Pages: 8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
01/11/2016
16:11
RNS Number : 9990N The MedicX Fund Limited 01 November 2016 Press Release For immediate release 1 November 2016 MedicX Fund Limited ("MedicX Fund", "the Fund" or "the Company") Notice of dividend The Directors have approved a quarterly dividend of 1.4875p per Ordinary Share in respect of the period 1 July 2016 to 30 September 2016. This will bring the total dividends declared in respect of the financial year ended 30 September 2016 to 5.95p per Ordinary Share, an increase of 0.85% over the dividends totalling 5.9p declared for the previous year ended 30 September 2015. The dividend will be paid on 31 December 2016 to ordinary shareholders on the register as at 18 November 2016 (the "Record Date"). The corresponding ex-dividend date will be 17 November 2016.
cheshire2
19/10/2016
14:13
Acquisition of new primary healthcare centre MedicX Fund, (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom and Ireland, is pleased to announce that it has contracted to acquire, by way of forward funding, a new primary healthcare medical centre in Brynmawr, South Wales. The property is due to be completed in November 2017. The acquisition is being made under the framework agreement with General Practice Investment Corporation ("GPI") which was agreed in May 2013. The completed development will be let to the Local Health Board and Bestway Pharmacy. All leases will be for a term of 20 years from practical completion. The completed property will consist of 1,587 m2 with an initial passing rent of approximately £300,000 per annum, subject to three-yearly effectively upwards only market rent reviews. The MedicX Fund's total property portfolio now comprises 153 properties throughout the United Kingdom and Republic of Ireland of which 146 are operational and fully let, with 7 under construction. The annualised rent roll for all properties is now £37.4 million. - End -
skinny
04/10/2016
12:37
RNS Number : 6600L The MedicX Fund Limited 04 October 2016 For immediate release 4 October 2016 MedicX Fund Limited ("MedicX Fund", "the Fund" or "the Company") Issue of ordinary shares MedicX Fund Limited announces that earlier today, Tuesday 4 October 2016, it issued for cash 2,000,000 ordinary shares of no par value in the Company. The ordinary shares were issued under the Company's block listing facility, at a price of 88.5 pence per share. This follows the issue of 1,000,000 ordinary shares earlier today at the same price. The net proceeds will be used in further pursuing the investment objectives of the Company.
cheshire2
28/9/2016
14:42
Another million there Skinny ..just in the rns section
badtime
23/9/2016
12:24
Issue of ordinary shares MedicX Fund Limited announces that earlier today, Friday 23 September 2016, it issued for cash 1,000,000 ordinary shares of no par value in the Company. The ordinary shares were issued under the Company's block listing facility, at a price of 88.25 pence per share. The net proceeds will be used in further pursuing the investment objectives of the Company. Total voting rights In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of ordinary shares in the capital of the Company in issue following this transaction will be 386,897,760 (excluding treasury shares) each with one voting right. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules. The Company also holds 8,354,422 ordinary shares in treasury and has 22,981,109 ordinary shares of no par value remaining under its block listing facility to be used to satisfy demand that cannot be met through the secondary market. - End -
skinny
23/9/2016
12:24
£20 million revolving loan facility MedicX Fund Limited (LSE: MXF), the specialist primary care infrastructure investor in modern purpose-built primary healthcare properties in the United Kingdom and Republic of Ireland, is pleased to announce that it has completed the amendment and restatement of its previous £25 million revolving credit facility. On 15 September 2016, the facility term was extended for a new three year term ending in September 2019. In addition, the amendment also provides for an option, with lender consent, that the immediately committed £20 million revolving credit facility may be extended by a further £10 million to £30 million or additional lenders be added with a view to increasing the facility on existing terms. Interest is payable on amounts drawn under the amended facility at a rate equal to LIBOR plus a lending margin of 2.00 per cent. per annum. A non-utilisation fee of between 1.10% and 0.75% will be payable on the reduced, £20 million immediately available commitment depending on the level of utilisation. The Fund has £337 million of other debt facilities with a weighted average fixed cost of 4.45% including undrawn amounts, with an average remaining term of just over 14 years. - End -
skinny
16/9/2016
14:14
£20 million revolving loan facility MedicX Fund Limited (LSE: MXF), the specialist primary care infrastructure investor in modern purpose-built primary healthcare properties in the United Kingdom and Republic of Ireland, is pleased to announce that it has completed the amendment and restatement of its previous £25 million revolving credit facility. On 15 September 2016, the facility term was extended for a new three year term ending in September 2019. In addition, the amendment also provides for an option, with lender consent, that the immediately committed £20 million revolving credit facility may be extended by a further £10 million to £30 million or additional lenders be added with a view to increasing the facility on existing terms. Interest is payable on amounts drawn under the amended facility at a rate equal to LIBOR plus a lending margin of 2.00 per cent. per annum. A non-utilisation fee of between 1.10% and 0.75% will be payable on the reduced, £20 million immediately available commitment depending on the level of utilisation. The Fund has £337 million of other debt facilities with a weighted average fixed cost of 4.45% including undrawn amounts, with an average remaining term of just over 14 years. - End -
skinny
19/8/2016
11:16
Made up the fall already
badtime
16/8/2016
11:27
Ex div Thursday
badtime
12/8/2016
15:08
Thanks speedsgh
chester
11/8/2016
14:25
New Edison research note out... More Irish expansion - HTTP://www.edisoninvestmentresearch.com/research/report/medicx-fund17/preview/
speedsgh
28/7/2016
12:15
A new high @91p.
skinny
28/7/2016
11:06
This share is beginning to pop again. Great yield, but the current share price is well above current NAV. This has kept the share price pegged in the high 80s. People are beginning to understand, however, that NAV will rise as the 15 or so medical centres in their construction phase come on line as rent generators. This is a rock solid high yield investment with further capital gains to come as new medical centres are commissioned.
ridicule
26/7/2016
13:54
Perhaps income seekers looking for a yield. Seems to be heading to 90p
rathkum
27/6/2016
14:10
81.5 earlier..just a few ..saving ammo for lower possibilities
badtime
27/6/2016
08:42
Bit lower and might add
badtime
16/6/2016
11:08
Drifting on rate fears through a possible no vote?
badtime
07/6/2016
12:11
Direct link available below to today's Edison note... Continuing to find opportunities - HTTP://www.edisoninvestmentresearch.com/research/report/medicx-fund16/full
speedsgh
25/5/2016
10:29
OK...2525 taken .
redips2
25/5/2016
07:55
Maybe time to take some more .
redips2
24/5/2016
08:09
Results for the six month period ended 31 March 2016 Financial results · 0.4 pence per share increase in EPRA NAV for the period to 31 March 2016 to 71.2 pence per share (30 September 2015: 70.8 pence per share) · Quarterly dividend of 1.4875p per share announced in April 20164; total dividends of 5.95p per share expected for the year or 6.8% dividend yield, an increase of 0.8% (2015: total dividends of 5.9p per share; 7.0% dividend yield)4,7 · EPRA earnings of £6.8 million, equivalent to 1.8p per share (31 March 2015: £7.0 million; 2.0p per share)8 · Dividend and underlying dividend cover of 63% and 71% for the six month period (31 March 2015: 67% and 67%)9 · EPRA NNNAV of £226.3 million equivalent to 60.3p per share (30 September 2015: 228.9 million; 62.7p per share)8 Investments · New committed investments between 1 October 2015 and 31 March 2016 of £27.4 million · £573.0 million committed investment in 151 primary healthcare properties, an increase of 2.4% over the period (4 December 2015: £559.5 million, 148 properties)1,10 · Annualised rent roll now £36.7 million with 87% of rents reimbursed by the NHS, an increase of £0.9 million, or 2.5%, since 4 December 20151 · Strong pipeline of approximately £144.0 million of further acquisition opportunities1 Funding · Market capitalisation £328.5 million1 including £8.5 million net proceeds raised from 10.0 million shares issued since 1 October 2015 at an average issue price of 85.0p per share · Total drawn debt facilities at 31 March 2016 of £337.4 million with an average all-in fixed rate of debt of 4.45% and an average unexpired term of 14.5 years, close to the average unexpired lease term of the investment properties of 15.7 years and compared with 4.45% and 15.0 years at 30 September 2015 · Net debt of £311.6 million equating to 52.3% adjusted gearing at 31 March 2016 (30 September 2015: £281.4 million; 50.2%)
skinny
21/4/2016
08:29
Could be pi's diversifying and taking a 7% yield...+ a little share price increase per annum gives a nice return. V good for an ISA.
ih_552354
21/4/2016
08:29
http://www.bbc.co.uk/news/health-36087286 Maybe .
redips2
Chat Pages: 8  7  6  5  4  3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20161205 12:33:21